Lu-177-ethylenedicysteine-glucosamine (CellPoint)

N/A

Report date: 2025/11/28 17:54:18
NME

Base Information

Drug NameLu-177-ethylenedicysteine-glucosamine (CellPoint)
Drug Alias Name177Lu-EC-G177Lu-Oncardia
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionSingle-photon emission-computed tomography enhancersApoptosis stimulantsIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellPoint LLC
China Registration ClassN/A

Develop Information

Active CompaniesCellPoint LLC
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A